BMS 6072
Generic Name: glyburide/metformin
Pill imprint BMS 6072 has been identified as Glucovance 1.25 mg / 250 mg.
Glucovance is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy.
Glucovance 1.25 mg / 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Glucovance Images
- Generic Name:
- glyburide/metformin
- Imprint:
-
BMS
6072 - Strength:
- 1.25 mg / 250 mg
- Color:
- Yellow
- Size:
- 13.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- microcrystalline cellulose
povidone
croscarmellose sodium
magnesium stearate
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00087-6072
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-4906 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Glucovance resources
- Glucovance
- Glucovance (Wolters Kluwer)
- Glucovance (Cerner Multum)
- Glucovance (Micromedex) - Includes Dosage Information
- Glucovance (FDA)
Search Again
